Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.24
+0.06000.33%
Post-market: 18.480.2400+1.32%18:12 EDT
Volume:2.23M
Turnover:40.65M
Market Cap:58.05B
PE:-57.28
High:18.26
Open:18.24
Low:18.11
Close:18.18
52wk High:18.90
52wk Low:12.99
Shares:3.18B
Float Shares:3.09B
Volume Ratio:0.84
T/O Rate:0.07%
Dividend:0.63
Dividend Rate:3.45%
EPS(TTM):-0.3184
EPS(LYR):-0.3042
ROE:-2.26%
ROA:2.69%
PB:1.22
PE(LYR):-59.95

Loading ...

Takeda announces Japan MHLW approval for Orzeyful

TIPRANKS
·
Yesterday

Takeda Secures Japan Approval for Orzeyful to Treat Narcolepsy Type 1

MT Newswires Live
·
Yesterday

Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Link Bilgisayar launches TÜBİTAK-backed smart city emission mapping project

TIPRANKS
·
Aug 12

Takeda award from Veterans Affairs posted to SAM.gov site

TIPRANKS
·
Aug 10

Takeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study

TIPRANKS
·
Aug 08

Analysts Conflicted on These Healthcare Names: Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinger (SDGR)

TIPRANKS
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Yomiuri: Japan Set to Approve Drug That Treats Narcolepsy

Dow Jones
·
Aug 06

Takeda Advances Pediatric Pouchitis Trial, Extending Entyvio’s Long‑Term Growth Story

TIPRANKS
·
Aug 04

Takeda Tracks Real World Safety of Ceprotin (TAK-662) in Rare Clotting Disorder

TIPRANKS
·
Aug 01

NYSE Order Imbalance 114898.0 Shares on Sell Side

THOMSON REUTERS
·
Jul 31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD)

TIPRANKS
·
Jul 31

Takeda Pharmaceutical Fiscal Q1 Core Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Takeda Pharmaceutical Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $7.655B Beat $7.060B Estimate

Benzinga Earnings
·
Jul 30

Press Release: Takeda Announces Fy2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Dow Jones
·
Jul 30

Takeda’s Pediatric GERD Trial Update: What Dexlansoprazole Data Could Mean for TAK Investors

TIPRANKS
·
Jul 30

Takeda Pharmaceutical Co Ltd Expected to Post Earnings of Jpy140.99 a Share - Earnings Preview

Reuters
·
Jul 28

Takeda Expected to Post Lower First-Quarter Net Profit

Dow Jones
·
Jul 28

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

TIPRANKS
·
Jul 25